PV
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open | 2025 | 108 | 257 | |||
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | 2025 | 84 | 416 | |||
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health | 2024 | 15 | 175 | |||
| Which trial do we need ? Randomized, placebo-controlled trial of antiviral treatment in patients hospitalized for influenza | Clinical microbiology and infection | 2024 | 32 | 272 | |||
| Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center | CMI communications | 2024 | 66 | 119 | |||
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders | 2024 | 10 | 111 | |||
| Identification of a measles variant displaying mutations impacting molecular diagnostics, Geneva, Switzerland, 2023 | Euro surveillance | 2024 | 78 | 149 | |||
| Ebola : d'un traitement symptomatique au déploiement de vaccins et de traitements spécifiques | 2024 | 123 | 58 | ||||
| Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort study | Swiss medical weekly | 2023 | 67 | 155 | |||
| The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll | Scientific reports | 2023 | 154 | 39 | |||
| Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital | Scientific reports | 2023 | 208 | 134 | |||
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | 2023 | 70 | 108 | |||
| Different virus, same mistakes: Why (re-) emerging viruses are one step ahead of us | The Innovation | 2022 | 265 | 95 | |||
| Spécificités de l’infection à SARS-CoV-2 chez les patients âgés | Revue médicale suisse | 2022 | 78 | 89 | |||
| One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals | Journal of internal medicine | 2022 | 273 | 129 | |||
| Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study | Journal of clinical medicine | 2022 | 176 | 169 | |||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 291 | 215 | |||
| Bas les masques, et après ? | Revue médicale suisse | 2022 | 70 | 97 | |||
| The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital | Preventive medicine reports | 2022 | 255 | 134 | |||
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | 2022 | 284 | 420 | |||
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization | Scientific reports | 2022 | 222 | 118 | |||
| Characteristics of long-COVID among older adults: a cross-sectional study | International journal of infectious diseases | 2022 | 167 | 226 | |||
| Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) | Swiss medical weekly | 2021 | 419 | 167 | |||
| Maladies infectieuses | Revue médicale suisse | 2021 | 392 | 116 | |||
| Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study | Journal of travel medicine | 2021 | 228 | 0 | |||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 527 | 348 | |||
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection | 2021 | 276 | 501 | |||
| Puumala Virus Infection in Family, Switzerland | Emerging Infectious Diseases | 2021 | 461 | 394 | |||
| Traitement du SARS-CoV-2 en pédiatrie : quelles évidences et quelle utilité ? | Revue médicale suisse | 2021 | 201 | 171 | |||
| Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases | 2021 | 509 | 272 | |||
| Covid-19: a puzzle with many missing pieces | BMJ (Clinical Research Edition) | 2020 | 342 | 542 | |||
| Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach | Clinical microbiology and infection | 2020 | 101 | 306 | |||
| Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV | PLoS biology | 2020 | 102 | 31 | |||
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | 2020 | 511 | 481 | |||
| Clinical features of covid-19 | BMJ | 2020 | 317 | 1 | |||
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 524 | 227 | |||
| Dexamethasone and remdesivir: finding method in the COVID-19 madness | The Lancet microbe | 2020 | 254 | 50 | |||
| Understanding the emerging coronavirus: what it means for health security and infection prevention | Journal of Hospital Infection | 2020 | 261 | 192 | |||
| New filovirus disease classification and nomenclature | Nature Reviews Microbiology | 2019 | 401 | 0 | |||
| Ebola Virus Shedding and Transmission: Review of Current Evidence | The Journal of Infectious Diseases | 2016 | 560 | 546 | |||
| Ebola virus disease diagnosis by real-time RT-PCR: A comparative study of 11 different procedures | Journal of clinical virology | 2016 | 670 | 495 | |||
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine | 2016 | 1,229 | 364 | |||
| Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone | Clinical infectious diseases | 2016 | 644 | 490 | |||
| Sequelae of Ebola virus disease: the emergency within the emergency | The Lancet Infectious Diseases | 2016 | 468 | 0 | |||
| The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control | 2016 | 548 | 260 | |||
| Ebola: le point au crépuscule d'une épidémie inattendue | Revue médicale suisse | 2015 | 142 | 284 | |||
| Infectiologie en 2014: une année virale | Revue médicale suisse | 2015 | 507 | 2 | |||
| Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases | 2015 | 715 | 1 |
